kcrch the methodology of use ,variations of the compound and other aspects of the process are covered by some granted patents (with additional applications pending ) held or controlled by the company. Additionally certain supply arrangements strengthen the I P. position commercially.
go to the company website for detail
https://paradigmbiopharma.com/investors/ip-patents-trademarks/
for more detail. Sammyall is correct however as the original compound seems to have been developed more than 60 years ago and is "known" hence no longer novel and not patentable .
kcrch the methodology of use ,variations of the compound and...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 09.50am 20/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
Day chart unavailable